Recent Trends in US Breast Cancer Incidence, Survival, and Mortality Rates -
KC Chu, RE Tarone, LG Kessler, LAG Ries, BF Hankey … - jnci, 1996 - jnci.oxfordjournals.org
... Statistical modeling indicates that the recent drop in breast cancer mortality is
too rapid to be explained only by the increased use of mammography; likewise ...
Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: … -
PH Zahl? - BMJ, 2004 - pubmedcentral.nih.gov
... Abstract. Objective To determine whether any increase in the incidence of breast
cancer in women detected by mammography is compensated for by a drop in the ...
… of patients with complete remission following combination chemotherapy for metastatic breast cancer -
PA Greenberg, GN Hortobagyi, TL Smith, LD Ziegler, … - Journal of Clinical Oncology, 1996 - jco.ascopubs.org
... at times ranging from 118 to 234 months, 18 patients died of breast cancer, and
one ... The hazard function shows a substantial drop in risk of progression after ...
… Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004 -
EP Winer, C Hudis, HJ Burstein, AC Wolff, KI … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org
... per day (the usual dose employed in the treatment of breast cancer) given on ... who
has truly become postmenopausal has already had a substantial drop in estrogen ...
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study. -
DM Schreinemachers, RB Everson - Epidemiology, 1994 - JSTOR
... anatomic sites, including bladder, breast, colon, esophagus ... on colon or small bowel
cancer in rodents ... US Environmental Protection Agency, Mail Drop 68, Research ...
Overview of the Main Outcomes in Breast Cancer Prevention Trials. -
J Cuzick, T Powles, U Veronesi, J Forbes, R … - Obstetrical & Gynecological Survey, 2003 - obgynsurvey.com
... be of definite benefit in reducing the risk of breast cancer in appropriate ... These
symptoms have been associated with the postmenopausal drop in estrogen levels ...
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and … -
M Colleoni, A Rocca, MT Sandri, L Zorzino, G Masci … - Annals of Oncology, 2002 - pt.wkhealth.com
... Conclusions: Continuously low-dose CTX and MTX is minimally toxic and effective
in heavily pretreated breast cancer patients. A drop in VEGF was associated ...
Palliative pamidronate treatment in patients with bone metastases from breast cancer -
AT van Holten-Verzantvoort, HM Kroon, OL Bijvoet, … - Journal of Clinical Oncology, 1993 - jco.ascopubs.org
... a 23% drop-out rate, but other cancer-associated factors seemed to contribute to
this toxicity. CONCLUSION: Pamidronate treatment of breast cancer patients ...
… Without Further Axillary Dissection in Patients With Sentinel Node-Negative Breast Cancer -
AE Giuliano, PI Haigh, MB Brennan, NM Hansen, MC … - Journal of Clinical Oncology, 2000 - jcojournal.org
... sentinel nodes before abandoning ALND as a staging technique in breast cancer patients
with ... will stabilize at about 2% to 5% but likely will never drop to zero ...
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal … -
RT Chlebowski, SL Hendrix, RD Langer, ML Stefanick … - JAMA, 2003 - geisingermedicalcenter.com
... RESULTS Breast cancer risk characteristics were closely comparable in the 2 ... Par-
ticipants were at moderate breast can- cer ... Drop-ins, based on women who self ...
Source: Google Scholar |